Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis, Moderate to Severe”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06176768
What this trial is testing

LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 33
Large-scale testing (Phase 3)Study completedNCT02016105
What this trial is testing

Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira

Who this might be right for
Plaque Type Psoriasis
Sandoz 465
Large-scale testing (Phase 3)Study completedNCT01624233
What this trial is testing

A Study in Japanese Participants With Moderate-to-Severe Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 91
Large-scale testing (Phase 3)Study completedNCT03051217
What this trial is testing

Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis

Who this might be right for
Moderate to Severe PsoriasisGeneralized Pustular Psoriasis and Erythrodermic Psoriasis
UCB Biopharma S.P.R.L. 127
Post-approval studies (Phase 4)Study completedNCT00833729
What this trial is testing

The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab

Who this might be right for
Plaque Psoriasis
Dermatrials Research 10
Early research (Phase 1)UnknownNCT04367441
What this trial is testing

Randomized, Double Blinded, Placebo Controlled, Single Dose Escalation Study of 608 in Healthy Subjects

Who this might be right for
Moderate to Severe Plaque Psoriasis
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 62
Large-scale testing (Phase 3)Study completedNCT03875508
What this trial is testing

Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 108
Large-scale testing (Phase 3)Study completedNCT02267135
What this trial is testing

Efficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp Psoriasis

Who this might be right for
Chronic Scalp Psoriasis
Novartis Pharmaceuticals 102
Large-scale testing (Phase 3)Not Yet RecruitingNCT07752108
What this trial is testing

Zasocitinib in Adults With Non-pustular Palmoplantar Psoriasis

Who this might be right for
Palmoplantar Psoriasis
Takeda 40
Large-scale testing (Phase 3)Ended earlyNCT01708629
What this trial is testing

Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects

Who this might be right for
Plaque Psoriasis
Bausch Health Americas, Inc. 1,881
Early research (Phase 1)Study completedNCT00937027
What this trial is testing

Aminopterin Pharmacokinetic Study In Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Syntrix Biosystems, Inc. 22
Testing effectiveness (Phase 2)WithdrawnNCT02011269
What this trial is testing

TSO for Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Coronado Biosciences, Inc.
Testing effectiveness (Phase 2)Study completedNCT01585233
What this trial is testing

A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Astellas Pharma Global Development, Inc. 60
Not applicableStudy completedNCT04823247
What this trial is testing

Observational Real-world Evidence (RWE) Study to Assess Patient-reported Wellbeing Using Tildrakizumab in Live Setting - POSITIVE Study

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 782
Not applicableLooking for participantsNCT06382051
What this trial is testing

Modifying PEST for Psoriatic Arthritis Screening

Who this might be right for
Plaque PsoriasisPsoriatic Arthritis
Novartis Pharmaceuticals 502
Testing effectiveness (Phase 2)Study completedNCT00147329
What this trial is testing

Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Merrimack Pharmaceuticals 30
Large-scale testing (Phase 3)Study completedNCT02387801
What this trial is testing

The Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 12
Testing effectiveness (Phase 2)Study completedNCT02106195
What this trial is testing

A Safety and Tolerability Study of Belumosudil (KD025) Treatment in Subjects With Moderately Severe Psoriasis Vulgaris

Who this might be right for
Psoriasis Vulgaris
Kadmon Corporation, LLC 8
Large-scale testing (Phase 3)Active Not RecruitingNCT04862286
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977

Who this might be right for
Psoriasis
AbbVie 132
Large-scale testing (Phase 3)Study completedNCT00251641
What this trial is testing

The Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 868
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation